Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 2011. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) rather than a comprehensive financial results report.
Key Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific share transaction.
Material Changes and Transactions
The filing details a transaction by Mr. E J Gray on December 1, 2011:
- Option Exercise: Exercised options to purchase 1,009 Ordinary shares granted on December 1, 2008, under the Sharesave Plan at a price of £9.51 per share.
- Share Sale: Sold 1,009 Ordinary shares on the same date at a price of £14.1351 per share.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a compliance notification under Disclosure Rule 3.1.4R(1)(a).
Investor Verification Points
- Verify the total number of shares held by Mr. E J Gray post-transaction.
- Confirm the current status of the GlaxoSmithKline plc Sharesave Plan.
- Review the full annual report (Form 20-F) for comprehensive financial performance data for the period ending December 2011.